DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "EPO Biosimilars - The Future of Erythropoietin Market" report to their offering.
The global erythropoietin market is anticipated to reach an approximate value of US$ 7 Billion by 2020. This report provides a detailed analysis of the current and future market scenario of the global erythropoietin market. The report highlights biosimilar erythropoietin at various stages of clinical development. In addition, the report provides insight about the major drivers and challenges, along with the latest trends and developments impacting the industry growth.
The global erythropoietin market has been segmented into biologic and biosimilar erythropoietin markets. The report also highlights the various biologic and biosimilar erythropoietin drugs currently available in the market. Furthermore, the global erythropoietin market has also been segmented on the basis of their applications. Based on geography, the report divides the market into the US, Europe, and Asia-Pacific.
The last section of the report discusses about the prominent players in global erythropoietin market. Market share analysis of these players is also provided in the report. A brief business overview and financial information about each of these players has been provided along with their product portfolios. The recent development of every player has also been presented in the report. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global erythropoietin market.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Industry Trends and Drivers
3.1 Biosimilars Opens Array of Opportunity for Market Growth
3.2 Growing Geriatric Population
3.3 Increasing Incidences of Chronic Diseases
3.4 Ability to Curb Healthcare Cost
4. Industry Challenges
4.1 High Prices
4.2 Stringent Regulatory Processes
4.3 Threat from Substitutes
5. Global Protein Therapeutics Market
5.1 Protein Therapeutics Market Vs Pharmaceutical Market
5.2 Current and Future Market Analysis for 2022
5.3 Market Segmentation
6. Erythropoietin Market - Introduction
7. Global Erythropoietin Market Outlook to 2022
8. Market Segmentation
8.1 By Type
8.1.1 Biologic
8.1.2 Biosimilar
8.2 By Application
8.3 By Drug
9. Global Erythropoietin Market by Geography
9.1.1 US
9.1.2 Europe
9.1.3 Asia-Pacific
10. Pipeline Analysis of Erythropoietin
11. Competitive Landscape
- Amgen Inc.
- Johnson & Johnson
- Novartis
- Pfizer Inc.
- Roche Group
For more information about this report visit http://www.researchandmarkets.com/research/542jvh/epo_biosimilars
Related Topics: Biosimilars and Biosuperiors, Liver and Kidney Disorders Drugs
